Nanostructure-enhanced platelet binding and hemostatic structures
View Patent ↗Methods, systems, and apparatuses for nanomaterial-enhanced platelet binding and hemostatic medical devices are provided. Hemostatic materials and structures are provided that induce platelet binding, including platelet binding and the coagulation of blood at a wound/opening caused by trauma, a surgical procedure, ulceration, or other cause. Example embodiments include platelet binding devices, hemostatic bandages, hemostatic plugs, and hemostatic formulations. The hemostatic materials and structures may incorporate nanostructures and/or further hemostatic elements such as polymers, silicon nanofibers, silicon dioxide nanofibers, and/or glass beads into a highly absorbent, gelling scaffold. The hemostatic materials and structures may be resorbable.
1. A platelet binding structure, comprising:
a base structure that comprises carboxymethylcellulose (CMC); and
a plurality of inorganic nanostructures incorporated with the base structure wherein the nanostructures are incorporated in the base structure at a density of between about 0.05 mg/cm 2 and about 100 mg/cm 2 ;
wherein the nanostructures are configured to induce platelet binding when the platelet binding structure is contacted with platelets.
2. The platelet binding structure of claim 1 , wherein the platelet binding structure is a hemostatic device, a wound dressing, a specific cell binding device, or a platelet filtration device.
3. The platelet binding structure of claim 1 , wherein the nanostructures comprise elongated nanofibers.
4. The platelet binding structure of claim 3 , wherein the nanostructures comprise silicon nanofibers and/or silicon dioxide nanofibers.
5. The platelet binding structure of claim 1 , wherein the nanostructures coat the base structure.
6. The platelet binding structure of claim 1 wherein the nanostructures are incorporated in the base structure at a density of between about 0.05 and 2 mg/cm 2 .
7. The platelet binding structure of claim 1 wherein the nanostructures are incorporated in the base structure at a density of between about 0.05 and 0.5 mg/cm 2 .
8. The platelet binding structure of claim 1 wherein at least about three times more platelets bind to the nanofiber coated CMC base structure as compared with an uncoated CMC base structure.
9. A method of inducing platelet adhesion, comprising:
contacting a plurality of inorganic nanostructures incorporated within a base structure comprising carboxymethylcellulose (CMC) with a population of platelets, wherein the nanostructures are incorporated in the base structure at a density of between about 0.05 mg/cm 2 and about 100 mg/cm 2 .
10. The method of claim 9 , further comprising suspending the inorganic nanostructures in a solvent and coating the base structure with the solvent prior to said contacting.
11. The method of claim 10 , wherein said coating comprises dip coating.
12. The method of claim 9 , wherein the nanostructures comprise elongated nanofibers.
13. The method of claim 12 , wherein the nanostructures comprise silicon nanofibers and/or silicon dioxide nanofibers.
14. The method of claim 9 , wherein the nanostructures are incorporated in the base structure at a density of between about 0.05 mg/cm 2 and about 2 mg/cm 2 .
15. The method of claim 9 , wherein the nanostructures are incorporated in the base structure at a density of between about 0.05 and 0 . 5 mg/cm 2 .
16. The method of claim 9 , wherein at least about three times more platelets bind to the nanofiber coated CMC base structure as compared with an uncoated CMC base structure.
17. A hemostatic structure, comprising:
a base structure that includes a first material capable of creating a gel when contacted with blood; and
a plurality of hemostatic inorganic nanoparticles incorporated with the base structure wherein the hemostatic nanoparticles have a density in the range of about 0.05 mg per square centimeter of the base structure and about 2 mg per square centimeter of the base structure;
wherein the hemostatic nanoparticles are configured to induce hemostasis when the hemostatic structure is contacted with blood.
18. The hemostatic structure of claim 17 , wherein the first material comprises carboxymethylcellulose.
19. The hemostatic structure of claim 17 , wherein the first material comprises alginic acid.
20. The hemostatic structure of claim 17 , wherein the first material is capable of absorbing at least 10 times its own weight in fluid.
21. The hemostatic structure of claim 17 , wherein the hemostatic nanoparticles comprise elongated nanofibers.
22. The hemostatic structure of claim 21 , wherein the hemostatic nanoparticles comprise silicon nanofibers and/or silicon dioxide nanofibers.
23. The hemostatic structure of claim 17 , wherein the hemostatic nanoparticles coat the base structure.
24. The hemostatic structure of claim 17 , wherein the base structure is porous.
25. A method for forming a hemostatic structure, comprising:
providing a base structure that includes a first material capable of creating a gel when contacted with blood; and
coating the base structure with a plurality of hemostatic inorganic nanoparticles comprising elongated silicon nanofibers and/or silicon dioxide nanofibers such that the nanoparticles are configured to induce hemostasis when the hemostatic structure is contacted with blood, wherein said coating comprises suspending the inorganic nanofibers in a solvent and coating the base structure with the solvent.
26. The method of claim 25 , wherein the base structure comprises carboxymethylcellulose.
27. The method of claim 25 , wherein said coating comprises dip coating.
28. The method of claim 27 , further comprising evaporating the solvent after said coating to leave a plurality of nanofibers attached to the base structure.
29. The method of claim 28 , wherein the nanofibers attach to the base structure substantially by Van der Waals attraction.